Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 97.7K | $7.47M | $76.41 | Jun 3, 2024 | Direct |
PIERIS PHARMACEUTICALS, INC. | Director | Common Stock | 45.4K | $721K | $15.88 | Dec 13, 2024 | Direct |
PIERIS PHARMACEUTICALS, INC. | Director | Common Stock | 5.88K | $93.4K | $15.88 | Dec 13, 2024 | by Trust |
Vaxart, Inc. | Director | Common Stock | 40.6K | $52.7K | $1.30 | Jun 11, 2024 | Direct |
Vaxart, Inc. | Director | Stock Option (right to buy) | 95.4K | Jun 11, 2024 | Direct | ||
PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 24.7K | Dec 13, 2024 | Direct | ||
BIOMARIN PHARMACEUTICAL INC | Director | Stock Option (Right to Buy Common Stock) | 0 | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVLA | PALVELLA THERAPEUTICS, INC. | Dec 13, 2024 | 1 | $0 | 4 | Dec 17, 2024 | Director |
PVLA | PALVELLA THERAPEUTICS, INC. | Dec 13, 2024 | 0 | $0 | 3 | Dec 16, 2024 | Director |
VXRT | Vaxart, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | Jun 3, 2024 | 3 | -$11 | 4 | Jun 4, 2024 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
VXRT | Vaxart, Inc. | Jun 26, 2023 | 2 | $0 | 4 | Aug 1, 2023 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | May 23, 2023 | 1 | $0 | 4 | May 24, 2023 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | May 12, 2023 | 3 | -$63 | 4 | May 17, 2023 | Director |
VXRT | Vaxart, Inc. | Aug 25, 2022 | 2 | $0 | 4 | Aug 25, 2022 | Director |
VXRT | Vaxart, Inc. | Aug 25, 2022 | 0 | $0 | 3 | Aug 25, 2022 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | Feb 25, 2022 | 2 | $318K | 4 | Feb 28, 2022 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |